Peptide Decoding
New?New to peptides?Start here →
Decoding

Orexin A_Dosage, benefits & legal status

Also known as hypocretin-1

Published July 22, 2026 · Updated September 22, 2026

A peptide studied for wakefulness and daytime energy.

WakefulnessNeuropeptideResearch only
Common vial size5 mg
DoseResearch only
FrequencyAs studied
RouteNasal spray
StatusResearch only
CycledNo established schedule

Common vial size is what vendors typically sell, not a recommendation. Enter your own vial in the calculator.

See how this dose compares across the library →

01

What is Orexin A?

Plain language first. The technical label stays, but it never stands alone.

Overview

It is studied as a nasal spray for wakefulness and daytime energy, with limited data.

The technical version

Orexin-A (hypocretin-1) is a natural brain peptide that keeps you awake and alert; people with narcolepsy lack it.

What it's used for

A peptide that promotes wakefulness and alertness, studied for narcolepsy and daytime energy.

02

How does Orexin A work?

What it does in the body, and where.

Orexin-A is the wakefulness signal. Narcolepsy is what happens when the neurons that make it are destroyed, which is unusually direct as disease mechanisms go.

  1. 01
    It binds orexin receptors that drive arousal
    Holding the brain in a waking state and stabilising the boundary between sleep and wake.
  2. 02
    The nasal route is an attempt to reach the brain directly
    The peptide does not cross from blood into brain well, so it is sprayed.
  3. 03
    Human evidence is one small pilot study
    A single intranasal dose in narcolepsy, crossover design, small numbers.
  4. 04
    The field has moved to oral small molecules
    Drugs like oveporexton activate the same receptor and can be swallowed, which is a more practical route than a nasal peptide.
Anatomical illustration highlighting brain
WHERE THIS COMPOUND IS THOUGHT TO ACT:
Brain

03

What else is it used for?

Each use below carries its own evidence level. Approved means regulators have cleared it for that purpose. Investigational means it is in trials. Early research means it is being studied and is not established.

  • Wakefulness and daytime alertnessEarly research
  • NarcolepsyInvestigational

The published record

Research index

7,352

Papers and trials about Orexin A

Searched: Orexin A, hypocretin-1.

283 papers tagged human · 118 not reviews or lab · 7 clinical trial publications

79 registered trials · 17 with posted results

Furthest stage reached: Published trials only, 7 clinical trial publications, no phased trial registered

Compare this against the whole library →

In animals281
In the lab8
Reviews115
Senior author shareSpread across many groups

Evidence summary

Counted from Europe PMC indexing, not read by a person; a human tag can land on reviews, commentary or lab papers; clinical trial publications is the narrower count. 500 papers and 79 trials indexed in detail.

Orexin A vial rendering
Compound field notes

At a glance

Four things to know about Orexin A

01

Evidence

Research only

02

Category

Longevity and energy

03

Common vial

5 mg

04

Half-life

Nothing published

04

How much, and do you cycle it?

The range, and whether you take breaks.

Research only, as studied. No established schedule No range

No published study has established how long to take this or whether a break is needed. Schedules quoted online come from vendors and forums, and different sources disagree.

Compare this against the whole library →

05

How long does it stay in the body?

The half-life, and where the figure comes from.

Nothing publishedNo figure

Nothing published for an administered dose. Papers reporting orexin levels measure what the body already contains.

You can compare this against the whole library to see where it sits.

06

What does it cost?

Typical dose and cost, in plain numbers.

The products priced here are not injected

Route: nasal spray. Three randomized trials in narcolepsy with cataplexy, all from one group in Kiel, gave orexin-A as a nasal spray: 0.1 mL into each nostril at one-minute intervals over ten minutes, roughly 2 mL in total. REM sleep and wake-to-REM transitions fell; daytime sleepiness did not improve. The published descriptions give the volume rather than an amount, and the milligram figures repeated online come from secondary write-ups we could not confirm at the paper, so we do not print one.

Cost per month
—
Cost per dose
—
Typical dose
100 mcg–400 mcg / dayCommunity practice
What it costs

Orexin A starts at $57.99 across 2 vendors.

2 listings, last read Oct 10, 2026. Shipping and card fees are not included.

See all 2 listings →
07

How do you store it?

Before mixing, and after.

Fridge after opening. Use within about 30 days.

Store sealed Orexin A in the fridge. Once opened, keep it upright in the fridge and plan to finish it inside roughly 30 days. Keep it out of light and do not freeze the liquid.

08

What are the side effects and cautions?

Known cautions and warnings for this compound.

Solubility, computed: 21% charged residues, 48% hydrophobic. Acid may help.

A first-pass rule from peptide manufacturers' guidance. It does not account for disulfide bridges, salt form or how the powder was dried, and it predicts what should be easy rather than what will happen in your vial.

Who should avoid it

Check these before anything else.
  • No formal contraindications established
  • Pregnancy

Stop and get help

These are emergencies. Seek care.
  • Signs of an allergic reaction

Common effects

Expected, and usually mild.
  • Used in small experimental human protocols without a robust controlled safety database

Where this page says nothing is established, that means nobody has studied it, not that a compound is safe.

09

Is Orexin A approved?

And where the numbers on this page come from.

No. Orexin A is not approved for any use, anywhere. It is sold labeled for laboratory research only, and there is no legal route to buy it for human use.

  • Approval status
    Research only
  • Route
    Nasal spray
  • Checked
    22 September 2026
  • Dose
    From community reports. No regulator or trial established this dose.
  • Vial size
    From what vendors typically list; not a recommendation.
  • Sources
    None traced yet.

What has happened recently

We have not yet written a full regulatory note for this compound. The status above is current as of the date shown.

Guides for this compound

Sources

No primary source has been traced for this compound yet. Treat everything on this page as unverified until one is. How we grade evidence

Beyond these, 579 records are indexed. Browse the records